Cryptotanshinone Is a Intervention for ER-Positive Breast Cancer: An Integrated Approach to the Study of Natural Product Intervention Mechanisms

• Main Authors: Huayao Li (Author), Chundi Gao (Author), Qing Liang (Author), Cun Liu (Author), Lijuan Liu (Author), Jing Zhuang (Author), Jing Yang (Author), Chao Zhou (Author), Fubin Feng (Author), Changgang Sun (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Resistance to endocrine therapy has hampered clinical treatment in patients with ER-positive breast cancer (BRCA). Studies have confirmed that cryptotanshinone (CPT) has cytotoxic effects on BRCA cells and can significantly inhibit the proliferation and metastasis of ER-positive cancer c...